Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients - Related Studies

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

This study is currently recruiting participants.

Study NCT00255918. Last updated on September 19, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia
		Psychotic Disorders

2	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

3	Interventions listed in this trial
		Placebo

4	Additional drug interventions recognized in this trial
		3-(2,4-dimethoxybenzylidene)anabaseine

5	More general drug interventions related to this trial
		Cholinergic Agents
		Cholinergic Agonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Nicotinic Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)